vs
爱尔康（ALC）与芝商所（CME）财务数据对比。点击上方公司名可切换其他公司
爱尔康的季度营收约是芝商所的1.4倍（$2.6B vs $1.9B），爱尔康净利率更高（6.8% vs 0.1%，领先6.7%），芝商所同比增速更快（14.5% vs 4.0%）
爱尔康是瑞美合资的制药及医疗器械企业，专注于眼健康护理产品领域。公司注册地为瑞士弗里堡州，全球总部设于日内瓦，核心运营基地位于美国得克萨斯州沃思堡，当地员工规模约4500人。
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业，为全球规模最大的金融衍生品交易所运营商，旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台，覆盖农产品、货币、能源等品类交易，同时持有标普道琼斯指数27%的股权。
ALC vs CME — 直观对比
营收规模更大
ALC
是对方的1.4倍
$1.9B
营收增速更快
CME
高出10.5%
4.0%
净利率更高
ALC
高出6.7%
0.1%
损益表 — Q2 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.6B | $1.9B |
| 净利润 | $176.0M | $1.2M |
| 毛利率 | 53.5% | — |
| 营业利润率 | 9.5% | 0.1% |
| 净利率 | 6.8% | 0.1% |
| 营收同比 | 4.0% | 14.5% |
| 净利润同比 | -21.1% | 20.7% |
| 每股收益（稀释后） | $0.35 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALCCME
| Q1 26 | — | $1.9B | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $2.6B | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $2.5B | $1.5B |
净利润ALCCME
| Q1 26 | — | $1.2M | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $908.0M | ||
| Q2 25 | $176.0M | $1.0B | ||
| Q1 25 | — | $956.2M | ||
| Q4 24 | — | $874.6M | ||
| Q3 24 | — | $912.8M | ||
| Q2 24 | $223.0M | $883.2M |
毛利率ALCCME
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 55.0% | — |
营业利润率ALCCME
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 63.3% | ||
| Q2 25 | 9.5% | 66.7% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 62.1% | ||
| Q3 24 | — | 64.6% | ||
| Q2 24 | 12.7% | 65.3% |
净利率ALCCME
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | 71.7% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | 6.8% | 60.6% | ||
| Q1 25 | — | 58.2% | ||
| Q4 24 | — | 57.3% | ||
| Q3 24 | — | 57.6% | ||
| Q2 24 | 8.9% | 57.6% |
每股收益（稀释后）ALCCME
| Q1 26 | — | — | ||
| Q4 25 | — | $3.24 | ||
| Q3 25 | — | $2.49 | ||
| Q2 25 | $0.35 | $2.81 | ||
| Q1 25 | — | $2.62 | ||
| Q4 24 | — | $2.40 | ||
| Q3 24 | — | $2.50 | ||
| Q2 24 | $0.45 | $2.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $2.4B |
| 总债务越低越好 | — | $3.4B |
| 股东权益账面价值 | $22.1B | — |
| 总资产 | $31.4B | $202.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALCCME
| Q1 26 | — | $2.4B | ||
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | $1.4B | $1.9B |
总债务ALCCME
| Q1 26 | — | $3.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ALCCME
| Q1 26 | — | — | ||
| Q4 25 | — | $28.7B | ||
| Q3 25 | — | $28.2B | ||
| Q2 25 | $22.1B | $27.7B | ||
| Q1 25 | — | $27.0B | ||
| Q4 24 | — | $26.5B | ||
| Q3 24 | — | $28.2B | ||
| Q2 24 | $20.9B | $27.6B |
总资产ALCCME
| Q1 26 | — | $202.0B | ||
| Q4 25 | — | $198.4B | ||
| Q3 25 | — | $187.1B | ||
| Q2 25 | $31.4B | $179.9B | ||
| Q1 25 | — | $157.8B | ||
| Q4 24 | — | $137.4B | ||
| Q3 24 | — | $137.8B | ||
| Q2 24 | $29.7B | $123.4B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
